ANIX
Anixa Biosciences Inc
2.80$
+3.3%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +152.4% | -96.8% | +20.8% | +206.9% | -77.5% | -100.0% | – | +482,126.6% | -100.0% | -100.0% | – | |
| – | +83.5% | -94.0% | -51.9% | +946.0% | -84.8% | -45.8% | +327.0% | -89.1% | +283.3% | -77.0% | -2.7% | |
| – | +233.9% | -98.5% | +212.3% | -92.7% | +345.6% | -207.7% | – | +1,943,961.4% | -100.0% | -175.5% | – | |
| – | -40.1% | +118.8% | +2.6% | +326.5% | -19.7% | -20.0% | +41.3% | +8.3% | -28.9% | +34.1% | -20.7% | |
| – | -14.0% | -50.9% | +62.8% | +56.7% | -18.1% | -1.2% | +26.4% | +1.4% | -12.3% | +18.2% | -10.8% | |
| – | -2.6% | -29.9% | +37.9% | +116.7% | -12.8% | -17.4% | +34.1% | +4.6% | -20.3% | +25.1% | -15.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -64.2% | +15.1% | -3.7% | -100.0% | – | – | -99.1% | +32,198.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -98.6% | -28.9% | +3,894.1% | -42.1% | -39.4% | -77.2% | -551.5% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.